WATCH TV LIVE

Tags: amgen | horizon therapeutics | ftc

FTC Allows Amgen to Go Ahead Wiith $28B Horizon Deal

(AP)

Friday, 01 September 2023 09:21 AM EDT

The U.S. Federal Trade Commission has allowed drugmaker Amgen Inc. to move ahead with its $27.8 billion deal to buy Horizon Therapeutics, the companies said Friday.

The FTC filed a lawsuit on May 16 aimed at stopping the transaction, but suspended its challenge in late August. The suspension enabled the agency to consider whether it should settle the case.

The Thousand Oaks, California-based company announced plans to buy Horizon in December last year.

Horizon's shares rose 2.8% in premarket trading.

Click Here to comment on this article

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

Yes, Send Me News Alerts via email

(Optional for Local News)

Privacy: We never share your email address.

Join the Newsmax Community

Read and Post Comments
Please review Community Guidelines before posting a comment.

TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.